201 related articles for article (PubMed ID: 15121067)
1. Primary hyperparathyroidism and arrhythmic storm in a patient with an implantable cardioverter defibrillator for primary prevention of sudden death.
Occhetta E; Bortnik M; Magnani A; Francalacci G; Vassanelli C
Europace; 2004 May; 6(3):184-8. PubMed ID: 15121067
[TBL] [Abstract][Full Text] [Related]
2. Recurrent ventricular arrhythmia storms in the age of implantable cardioverter defibrillator therapy: a comprehensive review.
Huang DT; Traub D
Prog Cardiovasc Dis; 2008; 51(3):229-36. PubMed ID: 19026857
[TBL] [Abstract][Full Text] [Related]
3. Diplopia associated with hyperparathyroidism: report of a case.
Forman BH; Ciardiello K; Landau SJ; Freedman JK
Yale J Biol Med; 1995; 68(5-6):215-7. PubMed ID: 8903046
[TBL] [Abstract][Full Text] [Related]
4. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
Sinha SK; Mehta D; Gomes JA
Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
6. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
7. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
[TBL] [Abstract][Full Text] [Related]
8. [Indications for the implantable cardiac defibrillator].
Ben Ameur Y; Baraket F; Terras M; Longo S; Kraiem S; Hmem M; Slimane ML
Tunis Med; 2003; 81 Suppl 8():601-12. PubMed ID: 14608747
[TBL] [Abstract][Full Text] [Related]
9. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
10. Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial--a prospective pilot study.
de Bie MK; Lekkerkerker JC; van Dam B; Gaasbeek A; van Buren M; Putter H; van Erven L; Bax JJ; Schalij MJ; Rabelink TJ; Jukema JW
Curr Med Res Opin; 2008 Aug; 24(8):2151-7. PubMed ID: 18561878
[TBL] [Abstract][Full Text] [Related]
11. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
Proclemer A; Ghidina M
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
[No Abstract] [Full Text] [Related]
12. [Electrical storm in patients with implantable cardioverter-defibrillator].
Mitręga K; Średniawa B; Kowalski O; Lenarczyk R; Musialik-Łydka A; Kalarus Z
Kardiol Pol; 2013; 71(2):198-201; discussion 202. PubMed ID: 23575717
[TBL] [Abstract][Full Text] [Related]
13. Successful parental use of an automated external defibrillator for an infant with long-QT syndrome.
Divekar A; Soni R
Pediatrics; 2006 Aug; 118(2):e526-9. PubMed ID: 16816007
[TBL] [Abstract][Full Text] [Related]
14. [The implantable cardioverter-defibrillator: sometimes necessary].
Smeets JL
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2113-5. PubMed ID: 15553353
[TBL] [Abstract][Full Text] [Related]
15. Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.
Tung R; Swerdlow CD
Circulation; 2009 Sep; 120(10):825-7. PubMed ID: 19704090
[No Abstract] [Full Text] [Related]
16. Primary hyperparathyroidism related to a parathyroid adenoma: the dramatic clinical evolution of a misdiagnosed patient and its surgical solution.
Colognesi A; de Tullio D; Messina F; Ferrocci G; Stano R; Azzena G
Minerva Chir; 2006 Feb; 61(1):51-6. PubMed ID: 16568023
[TBL] [Abstract][Full Text] [Related]
17. Reversible parkinsonism induced by hypercalcemia and primary hyperparathyroidism.
Kovacs CS; Howse DC; Yendt ER
Arch Intern Med; 1993 May; 153(9):1134-6. PubMed ID: 8481080
[TBL] [Abstract][Full Text] [Related]
18. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
Klein MH; Gold MR
Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
[TBL] [Abstract][Full Text] [Related]
19. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
